
New research reveals that discontinuing long-term benzodiazepine therapy may increase risks of mortality and other adverse outcomes, challenging common assumptions.
Dr Kartiko is a third-year psychiatry resident at Creighton University.
New research reveals that discontinuing long-term benzodiazepine therapy may increase risks of mortality and other adverse outcomes, challenging common assumptions.
Published: April 16th 2025 | Updated: